Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis

被引:24
作者
Ross, S
Spencer, SD
Lasky, LA
Koeppen, H
机构
[1] Genentech Inc, Dept Pathol, S San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA
关键词
D O I
10.1016/S0002-9440(10)64028-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prostate stem cell antigen (PSCA) is a GPI-anchored membrane protein whose expression is reportedly up-regulated in a majority of human prostate cancers, including advanced stages and metastases, In this study, we investigate the expression pattern of the murine orthologue of PSCA by in situ hybridization in fetal and adult mouse tissues. Murine PSCA is expressed during fetal development in the urogenital sinus, skin, and gastrointestinal tract. The expression in these tissues is restricted to the most superficial cell layer. In the adult mouse, expression is highest in the mucosal lining of the urinary tract. In the normal adult prostate, expression of PSCA is detected exclusively in the secretory epithelium. Examination of PSCA during carcinogenesis of the murine prostate in the transgenic adenocarcinoma of the mouse prostate model showed a markedly increased expression in areas of neoplasia. The transgenic adenocarcinoma of the mouse prostate model may represent a valuable model for the study of PSCA as a potential target for immunotherapy of prostate cancer, despite potential differences in the pattern of expression between mice and humans.
引用
收藏
页码:809 / 816
页数:8
相关论文
共 22 条
[1]   Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors [J].
Bahrenberg, G ;
Brauers, A ;
Joost, HG ;
Jakse, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (03) :783-788
[2]   THE HUMAN E48 ANTIGEN, HIGHLY HOMOLOGOUS TO THE MURINE LY-6 ANTIGEN THB, IS A GPI-ANCHORED MOLECULE APPARENTLY INVOLVED IN KERATINOCYTE CELL-CELL ADHESION [J].
BRAKENHOFF, RH ;
GERRETSEN, M ;
KNIPPELS, EMC ;
VANDIJK, M ;
VANESSEN, H ;
WEGHUIS, DO ;
SINKE, RJ ;
SNOW, GB ;
VANDONGEN, GAMS .
JOURNAL OF CELL BIOLOGY, 1995, 129 (06) :1677-1689
[3]   Basic science aspects of prostate cancer [J].
Dorkin, TJ ;
Neal, DE .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (01) :21-27
[4]   Pathologic progression of autochthonous prostate cancer in the TRAMP model [J].
Gingrich, JR ;
Barrios, RJ ;
Foster, BA ;
Greenberg, NM .
PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (02) :70-75
[5]  
Gingrich JR, 1996, CANCER RES, V56, P4096
[6]  
Gingrich JR, 1997, CANCER RES, V57, P4687
[7]   PROSTATE-CANCER IN A TRANSGENIC MOUSE [J].
GREENBERG, NM ;
DEMAYO, F ;
FINEGOLD, MJ ;
MEDINA, D ;
TILLEY, WD ;
ASPINALL, JO ;
CUNHA, GR ;
DONJACOUR, AA ;
MATUSIK, RJ ;
ROSEN, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3439-3443
[8]   Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer [J].
Gu, Z ;
Thomas, G ;
Yamashiro, J ;
Shintaku, IP ;
Dorey, F ;
Raitano, A ;
Witte, ON ;
Said, JW ;
Loda, M ;
Reiter, RE .
ONCOGENE, 2000, 19 (10) :1288-1296
[9]  
Jenkins RB, 1997, CANCER RES, V57, P524
[10]  
LU LH, 1994, CELL VISION, V1, P169